Capital Fund Management S.A. Halozyme Therapeutics, Inc. Transaction History

Capital Fund Management S.A.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$33.68 - $41.95 $624,797 - $778,214	18,551 Added 45.25%	59,552 $2.42 Million
Q4 2023 Feb 14, 2024	BUY	$33.32 - $42.1 $893,275 - $1.13 Million	26,809 Added 188.9%	41,001 $1.52 Million
Q3 2023 Nov 14, 2023	BUY	$36.46 - $44.03 $517,440 - $624,873	14,192 New	14,192 $542,000

543

125M

294K

180K

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $6.57B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

Get notified when there are updates to the investment portfolio of Capital Fund Management S.A., based on Form 13F filings with the SEC.

Stay updated on Capital Fund Management S.A. with notifications on news.